838
Niacin extended - release / lovastatin is a new combination product approved for treatment of primary hypercholesterolemia and mixed dyslipidemia .
 Chemical: Niacin extended - release / lovastatin; Disease: hypercholesterolemia; Disease: dyslipidemia
Please list all entity words in the text that fit the category.Output format is "type1: word1; type2: word2". 
Option: Disease, Chemical 
Text: {0} 
Answer:
 Chemical: Niacin extended - release / lovastatin; Disease: hypercholesterolemia; Disease: dyslipidemia